Found: 8
Select item for more details and to access through your institution.
The Establishment and Identification of Acute Myeloid Leukemia NOD-SCID-IL2rg<sup>-/-</sup>Mice Model by Using Luciferase-Expressing KGla Cells.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2021, v. 29, n. 5, p. 1429, doi. 10.19746/j.cnki.issnl009-2137.2021.05.010
- By:
- Publication type:
- Article
CLAT方案治疗难治性急性髓系白血病的疗效观察.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2016, v. 24, n. 2, p. 399, doi. 10.7534/j.issn.1009-2137.2016.02.017
- By:
- Publication type:
- Article
c-kit Mutation in Acute Myeloid Leukemia Patients with AML1-ETO Fusion Gene and Its Clinical Significance.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2013, v. 21, n. 4, p. 839, doi. 10.7534/j.issn.1009-2137.2013.04.005
- By:
- Publication type:
- Article
Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 6, p. 1805, doi. 10.1007/s12094-023-03079-8
- By:
- Publication type:
- Article
Allogeneic Bone-Marrow-Derived Mesenchymal stromal Cells Expanded in vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 10, p. 1949, doi. 10.1002/sctm.12206
- By:
- Publication type:
- Article
Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 7, p. 1569, doi. 10.1002/sctm.16-0227
- By:
- Publication type:
- Article
Imatinib compared with second‐generation tyrosine kinase‐inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. E183, doi. 10.1002/ajh.26943
- By:
- Publication type:
- Article
Mutant C/EBPα p30 alleviates immunosuppression of CD8<sup>+</sup> T cells by inhibiting autophagy‐associated secretion of IL‐1β in AML.
- Published in:
- Cell Proliferation, 2022, v. 55, n. 12, p. 1, doi. 10.1111/cpr.13331
- By:
- Publication type:
- Article